At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 13 enrolled
Drug / intervention
Inhaled Nitric Oxide +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Respiratory Mechanics Following Brain Injury: The Role of Inhaled Nitric Oxide
In Brief
A Phase 3 clinical trial evaluating Inhaled Nitric Oxide and Placebo for Traumatic Brain Injury. Completed, enrolled 13 participants across 1 site.
Detailed Summary
This study will evaluate the changes in respiratory mechanics following traumatic brain injury and determine the effect of inhaled nitric oxide on gas exchange.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTraumatic Brain Injury
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
201820192020202120222023202420252026
First PostedAug 2017
Enrollment StartDec 2018
Primary CompletionDec 2023
TodayJul 2026
First PostedAug 24, 2017
Enrollment StartDec 12, 2018
Primary CompletionDec 28, 2023
TodayJul 2, 2026
Enrollment to primary: 5.0 yearsPosted 8.9 years ago
Interventions
Inhaled Nitric Oxidedrug
Patients randomized to this arm will receive inhaled nitric oxide 20 parts per million.
Placebodrug
Nitrogen plus oxygen